Considering AAA etiology, pro-inflammatory markers such as interleukin (IL)-33 and its decoy receptor, soluble suppression of tumorigenesis 2 (sST2), may potentially reflect the AAA disease state and thus seem promising parameters for risk stratification [10]. The gene discussed is IL33; the disease is triple-A syndrome.